An international, biospecimen registry on Staphylococcus aureus in fixation or arthroplasty showed higher rates of MRSA in North American patients and poorer subjective outcomes among those with MRSA vs. methicillin-sensitive S. aureus. Researchers …
Medicines Discovery Catapult (MDC) announced the rapid expansion of its Biosamples supply network, creating one of the largest virtual biobanks worldwide accessible to life science innovators. MDC welcomed Audubon Biosciences, Biomex, Caltag Medsystems and Tissue …
The Assembly of Members of the Biobanking and BioMolecular resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC) appointed Professor Jens K. Habermann as the new Director-General. The distinguished scientist, …
Glomerular diseases, a set of debilitating and complex clinical disease entities affecting individuals of all ages, are associated with significant mortality and morbidity, including hospitalization and ESRD. Although there are …
The microbiome research field is rapidly evolving, but the required biobanking infrastructure is currently fragmented and not prepared for the biobanking of microbiomes. The rapid advancement of technologies requires an …
The Cornell Veterinary Biobank has received a $2.5 million federal grant to process, store and distribute biological samples for the Dog Aging Project, a massive national effort to study aging in dogs …
The University of Cyprus (UCY) adopts OpenSpecimen as its Biobanking LIMS. The Molecular Medicine Research Center (MMRC), now known as CY-Biobank is the first research center of UCY. It aims at developing front-line research …
The establishment of a COVID-19 biorepository of specimens from the maternal-neonatal dyad is a critical first step to answering questions about the impact of COVID-19 infection on the pregnant patient …
Pediatric hydrocephalus is a devastating and costly disease. The mainstay of treatment is still surgical shunting of cerebrospinal fluid (CSF). These shunts fail at a high rate and impose a …
The COVID-19 pandemic highlights the risks associated with the collection and processing of human biospecimens with an unknown status for the coronavirus SARS-CoV-2, whether for diagnostic, therapeutic, or research purposes. …